ArticleFrontiers in pediatrics2025
Case Report: Refractory systemic nmastocytosis with AML1::ETO+ acute myeloid leukemia driven by rare KIT mutation: remarkable therapeutic efficacy of avapritinib.
Song Xue et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.